Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Shares Outstanding (Diluted Average) (2021 - 2025)

Kezar Life Sciences' Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $7.3 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) changed 0.23% year-over-year to $7.3 million; the TTM value through Sep 2025 reached $7.3 million, changed 0.23%, while the annual FY2024 figure was $7.3 million, 0.48% changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2025 was $7.3 million at Kezar Life Sciences, roughly flat from $7.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $72.5 million in Q2 2023 and bottomed at $6.7 million in Q4 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $7.3 million (2025), against an average of $31.2 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) increased 27.2% in 2022 before it tumbled 89.95% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $52.8 million in 2021, then plummeted by 87.23% to $6.7 million in 2022, then increased by 7.7% to $7.3 million in 2023, then rose by 0.48% to $7.3 million in 2024, then increased by 0.32% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for KZR's Shares Outstanding (Diluted Average) are $7.3 million (Q3 2025), $7.3 million (Q2 2025), and $7.3 million (Q1 2025).